FDALabeling Plan Will Fail
Unless It Is Mandatory
by
Brett ..Posted
Thu 22 Oct 2009 10:04pm
that considered Cocoa Krispies and Froot Loops a “Smart Choice?”
Apparently so, but it seems the Food and DrugAdministration is (sort 0f) running out of patience. The agency announced... the food products instead of only happy half-truths.
Apparently, the FDA is interested in a British labeling system that mimics traffic symbols for fat, saturated fats, sugars
Read on »
Food, grocery trade associations preempt FDAlabeling plans
by
Dr. Marion NestlePosted
Thu 28 Oct 2010 6:19am
rhetoric.
There is only one explanation for this move: heading off the FDA’s Front-of-Package (FOP) labeling initiatives.
Only two weeks ago, the Institute of Medicine released its first FDA-sponsored FOP labeling report. The IOM committee recommended that FOP symbols only mention calories, sodium, trans fat, and saturated fat. This led William
Read on »
Botox-Lawsuits, Fines, Suing the FDA and Now Waiting To Get Off Label Approval from the FDA for Migraines
by
Medical QuackPosted
Wed 08 Sep 2010 5:57pm
Botox Injections – Sales Representative Testified To Providing Off-label Dosing In A Sealed Envelope - Allergan
The FDA has given approval for Botox for use with muscle spasms... excitement for a forthcoming product or application.
“What concerns F.D.A. is that, if companies can promote off-label uses without submitting evidence showing the drug to be safe
Read on »
Tysabri PML Cases in Europe Prompt FDA to Seek Labeling Change
by
stuartPosted
Wed 14 Jan 2009 8:24pm
European cases of progressive multifocal leukoencephalopathy (PML). The U.S. Food & DrugAdministration (FDA) said it is working with Elan and Biogen Idec, the manufacturers of Tysabri, to amend the product labeling to inform prescribers and patients that cases of PML have occurred in patients taking Tysabri as monotherapy.
In the U.S. Tysabri was taken
Read on »
FDA changes labeling for cetuximab and panitumumab
by
Mark Pool, MDPosted
Wed 22 Jul 2009 12:00am
Finally, the FDA announced labeling changes to the anti-EGFR MoAbs cetuximab and panitumumab to reflect the overwhelming evidence supporting the benefit... there will be more uptake of KRAS mutation testing since there was still some confusion out there on the "best" way to test for EGFR because of the delay of the FDA to change the labelingRead on »
FDA Requests Labelling Change for Asthma Medications
by
COPDsurvivorPosted
Sun 14 Jun 2009 11:23pm
The US Food and DrugAdministration (FDA) today provided further updated safety information on leukotriene modifiers.
The FDA has requested that manufacturers include a precaution in the drug labelling regarding neuropsychiatric events that have been reported in some persons taking montelukast (Singulair), zafirlukast (Accolate), and zileuton (Zyflo
Read on »
FDA: Byetta Label Revised to Include Safety Information on Possible Kidney Problems
by
Health: Hearsay & HeadlinesPosted
Mon 02 Nov 2009 10:02pm
The U.S. Food and DrugAdministration today acted on new safety information about possible kidney function problems, including kidney failure, in patients taking Byetta... the known risks and benefits of Byetta, the FDA worked with the manufacturer to update the drug’s prescribing information (label). A description of these label changes can be found
Read on »
FDA: Byetta Label Revised to Include Safety Information on Possible Kidney Problems
by
Health: Hearsay & HeadlinesPosted
Wed 04 Nov 2009 10:04pm
The U.S. Food and DrugAdministration today acted on new safety information about possible kidney function problems, including kidney failure, in patients taking Byetta... the known risks and benefits of Byetta, the FDA worked with the manufacturer to update the drug’s prescribing information (label). A description of these label changes can be found
Read on »